Skip to main content
Premium Trial:

Request an Annual Quote

Arizona Centers Team on Heart, Vascular Studies

NEW YORK (GenomeWeb News) – Arizona Heart Institute and Arizona Research Center will partner on cardiovascular research that will include genomics, epigenetics, and large, multi-center drug and medical device trials, AHI said today.

The collaboration, focused on heart and vascular diseases, will give AZRC access to patients that may qualify for pharmaceutical and device research studies, and will enable AHI to pursue epigenetic and genomic studies in efforts to develop early-stage diagnostics that could allow for interventions before symptoms present.

AZRC represents a network of doctors and hospitals that support its research, and AHI includes the Arizona Heart Hospital and the Arizona Heart Institute Translational Research Center.

The Scan

Back as Director

A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports.

Research, But Implementation?

Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR.

For the False Negatives

The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results.

Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More

In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.